Table 3 Impact of the PLIN rs4578621 SNP on clinical variables in men and women separately
From: Study of the impact of perilipin polymorphisms in a French population
Men | Women | |||
|---|---|---|---|---|
CC 487 | CG+GG 81 | CC 462 | CG+GG 80 | |
Weight, kg | 79.9 ± 13.6 | 79.6 ± 12.9 | 68.1 ± 14.5 | 70.8 ± 15.2 |
BMI, kg/m2 | 26.7 ± 4.2 | 26.0 ± 3.6 | 26.4 ± 5.4 | 27.3 ± 5.9 |
Waist, cm | 96.2 ± 11.0 | 95.2 ± 9.8 | 85.3 ± 13.8 | 87.9 ± 15.0 |
Hip circ., cm | 101.5 ± 7.4 | 101.6 ± 6.8 | 103.5 ± 11.6 | 105.0 ± 12.7 |
WHR | 0.95 ± 0.07 | 0.94 ± 0.06 | 0.82 ± 0.08 | 0.83 ± 0.08 |
Leptin, ng/mL† | 9.48 ± 7.75 | 18.16 ± 6.59 | 24.08 ± 13.90 | 24.17 ± 14.98 |
Cholesterol, mmol/L | 5.88 ± 1.06 | 5.92 ± 0.94 | 5.92 ± 1.11 | 6.08 ± 1.13 |
HDL-chol., mmol/L | 1.34 ± 0.42 | 1.31 ± 0.36 | 1.67 ± 0.49 | 1.66 ± 0.49 |
LDL-chol., mmol/L | 3.86 ± 1.02 | 3.89 ± 0.86 | 3.71 ± 1.04 | 3.90 ± 1.08 |
Triglycerides, mmol/L † | 1.64 ± 1.38 | 1.69 ± 1.52 | 1.19 ± 0.80 | 1.25 ± 1.37 |
Glucose, mmol/L † | 5.66 ± 1.37 | 5.52 ± 1.45 | 5.33 ± 1.28 | 5.56 ± 1.41 |
Insulin, μU/mL † | 12.37 ± 9.35 | 11.95 ± 10.01 | 11.63 ± 6.00 | 12.06 ± 5.84 |